急性胸痛早期鉴别和危险分层的生物标志物检测

摘要

急性胸痛是急诊科常见的急危重症.急性胸痛的病因复杂,涉及多个系统和器官,所以在临床中,对急性胸痛的早期鉴别是急诊科的难点.同时在救治过程中,存在着高危患者救治不利、低危患者过度诊治的问题,因此,准确及时地进行危险分层就变得至关重要.近年来,随着许多新型生物标志物的发现及其研究的不断深入,显著促进了急性胸痛早期鉴别和危险分层领域的进展,本文将对此进行介绍.%Chest pain is among the most frequent cause of emergence department (ED) encounters.The etiological factors of chest pain are various and complex,which make early diagnosis remains a clinical challenge.Even worse,on account of the difficulty in rapid risk stratification,some high-risk patients didnt get optimal therapy,whereas low-risk patients got unnecessary hospitalization and extensive evaluation.With the quick development of biomarkers,early diagnosis and risk stratification becomes possible.In this paper,a systemic review of these biomarkers was performed.